Occult lymph node metastases in patients with 'node negative' breast carcinoma treated with conservation surgery and axillary node sample and who subsequently developed axillary recurrence

Breast

Volumn 11, Issue 3, 2002, Pages 249-251

  Murray, K L ^a   Lambah, P A ^b   Anderson, T J ^a   Dixon, J M ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CYTOKERATIN; EOSIN; HEMATOXYLIN; MUCIN 1;

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OCCULT CANCER; PATHOLOGIST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TISSUE SECTION;

EID: 0036312081     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2001.0399     Document Type: Article

References (12)

1. Predictors of recurrence in Stage 1 (TIN1M0) breast carcinoma
2. Occult axillary node metastases in breast cancer: Their detection and prognostic significance
3. The significance of breast cancer lymph node micrometastases
4. Occult regional lymph node metastases from breast carcinoma: Immunohistological detection with antibodies Cam 5.2 and NCRC-11
5. Axillary node sampling in breast cancer: And assessment of its efficacy
6. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma
7. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancers
8. The Almanac Trial: Initial experience
9. The challenge of sentinel lymph node biopsy
10. Classification of isolated tumour cells and micrometastasis
11. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy